Trial intelligence / Profile preview

Cumulative Irritation Patch Test of Butenafine HCl 1% Cream

NCT04531813Phase 3Completed

Sponsor
Bayer
Start
Jun 2013
Primary completion
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of butenafine in tinea pedis, sponsored by Bayer. Started Jun 2013; status: completed.

02

Drugs

butenafine
03

Conditions

tinea pedis

Beyond the preview

Go deeper on NCT04531813.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04531813.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call